The recommendations come at a time when treatments for chronic lymphocytic leukemia (CLL), such as venetoclax, are making deep remissions and undetectable minimal residual disease (MRD) after a fixed ...
Test detects genetic abnormalities to aid in the prediction of chronic lymphocytic leukemia patient survival. Abbott received 510k clearance for an in vitro diagnostic test to aid in determining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback